GLP-1 Agonist Acid Salt Patent Application
Summary
The USPTO published patent application US20260098042A1 for a novel acid salt form of a GLP-1 receptor agonist (OAD2) invented by Haiwen HU, Li FANG, Fan HU, Xinjie ZHOU, and Fenfen CHEN. The compound is classified under CPC C07D 491/056 and may be useful in treating type 2 diabetes and metabolic disorders. The application was filed August 19, 2025, and published April 9, 2026.
What changed
The USPTO published patent application US20260098042A1 for a novel acid salt form of OAD2, a GLP-1 receptor agonist, with a preparation method. The compound falls under CPC classification C07D 491/056 (heterocyclic compounds with oxygen-containing rings). The application indicates potential therapeutic use for type 2 diabetes.
Affected parties including pharmaceutical manufacturers, drug developers, and researchers working on GLP-1 based therapies should monitor this application for potential freedom-to-operate implications. The publication represents an early-stage IP filing that may eventually grant market exclusivity for the specific salt form and preparation method described.
What to do next
- Monitor for patent grant or office action
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHARMACEUTICALLY ACCEPTABLE ACID SALT OF FREE BASE OF GLP1 RECEPTOR AGONIST, AND PREPARATION METHOD THEREFOR
Application US20260098042A1 Kind: A1 Apr 09, 2026
Inventors
Haiwen HU, Li FANG, Fan HU, Xinjie ZHOU, Fenfen CHEN
Abstract
The invention provides pharmaceutically acceptable acid salts of (S)-2-(3S,8S)-3-(4-(3,4-dichlorobenzyloxy)phenyl-7-((S)-1-phenylpropyl)-2,3,6,7,8,9-hexahydro-[1,4]-dioxino[2,3-g]isoquinolin-8-ylformylamino)-3-(4-(2,3-dimethylpyridin-4-yl)phenyl) propionic acid (“OAD2”) and the preparation method thereof. The pharmaceutically acceptable acid salts of OAD2 provided herein may be useful in the treatment of various conditions and metabolic disorders including, but not limited to, type 2 diabetes.
CPC Classifications
C07D 491/056 C07B 2200/13
Filing Date
2025-08-19
Application No.
19304270
Related changes
Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.